about
Lipid-modifying therapy in the elderlyShould we lower cholesterol as much as possible?Efficacy and safety of statin monotherapy in older adults: a meta-analysis.Safety of statins.Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years.Discontinuation of statins in a population of older New Zealanders with limited life expectancy.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Implications of statin adverse effects in the elderly.
@en
Implications of statin adverse effects in the elderly.
@nl
type
label
Implications of statin adverse effects in the elderly.
@en
Implications of statin adverse effects in the elderly.
@nl
prefLabel
Implications of statin adverse effects in the elderly.
@en
Implications of statin adverse effects in the elderly.
@nl
P2860
P356
P1476
Implications of statin adverse effects in the elderly.
@en
P2093
Beatrice Alexandra Golomb
P2860
P304
P356
10.1517/14740338.4.3.389
P407
P577
2005-05-01T00:00:00Z